Volume: August 2024, Issue 1

Aug 2, 2024 | Hot Topics

Access to Hot Topics is a Benefit of AARS Membership

Beginning October 1, access to Hot Topics will require member log-in.
Not a member? Join Now!

New Medical Research

  • A dermocosmetic product containing the sap of oat plantlets and Garcinia mangostana extract improves the clinical signs of acne.
  • Investigating Propionibacterium acnes antibiotic susceptibility and response to bacteriophage in vitro and in vivo.
  • Social media use as a source of information by acne vulgaris patients.
  • Enhanced antibacterial activity of clindamycin using molecularly imprinted polymer nanoparticles loaded with polyurethane nanofibrous scaffolds for the treatment of acne vulgaris.
  • Advancing precision acne therapy using a novel photopneumatic device.
  • Pilot and quantitative evaluation of the TARGET acne toolkit by UK pharmacy professionals working in general practice.
  • Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate-to-severe facial acne vulgaris: A phase 3, multi-centre, randomized, double-blind, vehicle-controlled study.
  • Role of vitamin D supplement adjunct to topical benzoyl peroxide in acne: A randomized double-blinded controlled study.
  • LncRNA NEAT1 targets miR-125/ADAM9 mediated NF-κB pathway in inflammatory response of rosacea.
  • Comparative transcriptome analysis of acne vulgaris, rosacea, and hidradenitis suppurativa supports high-dose dietary zinc as a therapeutic agent.
  • Prevalence and factors associated with olfactory impairment among patients with acne treated with oral isotretinoin: A cross-sectional study.

Clinical Reviews

  • Visible light in the treatment of acne vulgaris.
  • Investigating the mechanism of PAD in the treatment of acne based on network pharmacology and molecular docking: A review.
  • Evaluating the internet as a source of information for patients with hidradenitis suppurativa: A review of websites’ content, insights into engagement, and access.
  • Treatment of rosacea with upadacitinib and abrocitinib: Case report and review of evidence for Janus kinase inhibition in rosacea.
  • Biologic drugs in hidradenitis suppurativa: what does the GP have to know? A narrative review.
  • PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome: A case report and review of the literature.
  • An overview on the management of atrophic acne scars: The role of trifarotene as an adjunct.
  • Adult female acne: Managing the hormones.
  • Health-related quality of life of patients with rosacea: A systematic review and meta-analysis of real-world data.
  • Potential role of tranexamic acid in rosacea treatment: Conquering flushing beyond melasma.

Related Posts

Volume: September 2024, Issue 1

Volume: September 2024, Issue 1

Access to Hot Topics is a Benefit of AARS Membership Beginning October 1, access to Hot Topics will require member log-in. Not a member? Join Now!AARS News Free CME Webinars from ARM/AARS Available Industry News Students with HS Among AbbVie Scholarship Recipients Oxy...

Volume: September 2024, Issue 1

Volume: August 2024, Issue 2

Access to Hot Topics is a Benefit of AARS Membership Beginning October 1, access to Hot Topics will require member log-in. Not a member? Join Now!AARS News AARS Program Explores Role of Emergency Contraception for Isotretinoin Prescribers Industry News Crown...

Volume: July 2024, Issue 1

Volume: July 2024, Issue 1

AARS News AARS July Membership Discount Available to HCPs Amid Paucity of Innovation, New Acne Treatment Guidelines Overlook Critical Issues: Editorial AARS Spotlights #AcneFacts During National Acne Awareness Month AARS Goes One-on-One with Dermatologist Sandra Lee,...

Volume: June 2024, Issue 1

Volume: June 2024, Issue 1

AARS News   Highlights from the 11th Annual AARS Annual Scientific Symposium New Medical Research Isotretinoin for acne in transgender and gender-diverse individuals receiving masculinizing hormone therapy. Efficacy and safety of bimekizumab in patients with...